Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$4.04 - $8.51 $79,470 - $167,400
-19,671 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$7.6 - $11.02 $10,526 - $15,262
-1,385 Reduced 6.58%
19,671 $149,000
Q4 2021

Feb 11, 2022

SELL
$10.16 - $16.17 $4,084 - $6,500
-402 Reduced 1.87%
21,056 $215,000
Q3 2021

Nov 12, 2021

SELL
$13.16 - $22.47 $6,711 - $11,459
-510 Reduced 2.32%
21,458 $288,000
Q2 2021

Aug 13, 2021

BUY
$19.57 - $26.32 $40,842 - $54,929
2,087 Added 10.5%
21,968 $482,000
Q1 2021

May 07, 2021

BUY
$17.58 - $32.59 $914 - $1,694
52 Added 0.26%
19,881 $478,000
Q4 2020

Feb 12, 2021

SELL
$10.99 - $20.4 $6,253 - $11,607
-569 Reduced 2.79%
19,829 $357,000
Q3 2020

Nov 04, 2020

SELL
$11.55 - $23.75 $5,359 - $11,020
-464 Reduced 2.22%
20,398 $236,000
Q2 2020

Aug 12, 2020

BUY
$9.57 - $24.37 $7,971 - $20,300
833 Added 4.16%
20,862 $506,000
Q1 2020

May 04, 2020

SELL
$9.07 - $26.32 $10,493 - $30,452
-1,157 Reduced 5.46%
20,029 $221,000
Q4 2019

Feb 05, 2020

SELL
$20.54 - $31.0 $3,676 - $5,549
-179 Reduced 0.84%
21,186 $560,000
Q3 2019

Nov 08, 2019

SELL
$22.78 - $40.58 $3,417 - $6,087
-150 Reduced 0.7%
21,365 $487,000
Q2 2019

Aug 13, 2019

BUY
$16.03 - $31.1 $107,737 - $209,023
6,721 Added 45.43%
21,515 $660,000
Q1 2019

May 06, 2019

SELL
$14.4 - $21.45 $3,024 - $4,504
-210 Reduced 1.4%
14,794 $246,000
Q4 2018

Feb 13, 2019

BUY
$16.51 - $51.33 $19,432 - $60,415
1,177 Added 8.51%
15,004 $287,000
Q3 2018

Nov 09, 2018

BUY
$43.15 - $67.97 $23,085 - $36,363
535 Added 4.02%
13,827 $723,000
Q2 2018

Aug 08, 2018

BUY
$35.06 - $51.17 $163,204 - $238,196
4,655 Added 53.9%
13,292 $578,000
Q1 2018

May 07, 2018

BUY
$19.05 - $41.76 $63,646 - $139,520
3,341 Added 63.09%
8,637 $320,000
Q4 2017

Feb 09, 2018

BUY
$19.01 - $26.2 $1,558 - $2,148
82 Added 1.57%
5,296 $105,000
Q3 2017

Nov 09, 2017

BUY
$12.53 - $27.12 $65,331 - $141,403
5,214
5,214 $130,000

Others Institutions Holding GTHX

About G1 Therapeutics, Inc.


  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.